Your browser doesn't support javascript.
loading
Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study.
Stein, Cy A; Levin, Richard; Given, Robert; Higano, Celestia S; Nemeth, Paul; Bosch, Bill; Chapas-Reed, Jillian; Dreicer, Robert.
Afiliação
  • Stein CA; Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA.
  • Levin R; Chesapeake Urology Research Associates, Towson, MD.
  • Given R; Urology of Virginia, Virginia Beach, VA.
  • Higano CS; Division of Medical Oncology, Seattle Cancer Care Alliance, University of Washington, Seattle, WA.
  • Nemeth P; Churchill Pharmaceuticals LLC, King of Prussia, PA. Electronic address: pnemeth@churchillpharma.com.
  • Bosch B; Churchill Pharmaceuticals LLC, King of Prussia, PA.
  • Chapas-Reed J; Churchill Pharmaceuticals LLC, King of Prussia, PA.
  • Dreicer R; Division of Hematology/Oncology, University of Virginia, Charlottesville, VA.
Urol Oncol ; 36(2): 81.e9-81.e16, 2018 02.
Article em En | MEDLINE | ID: mdl-29150328
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article